We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Natalia
Khovanova
n.khovanova@warwick.ac.uk
Diane
Sambrook
diane.sambrook@uhcw.nhs.uk
Other maternal disorders predominantly related to pregnancy
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance resulting in hyperglycaemia and impaired glucose tolerance, with first onset or detection during pregnancy. GDM increases the risk of complications for both mother and child during pregnancy, childbirth and beyond with increasing prevalence, estimated to affect 7% of all pregnancies. Evidence suggests early detection and treatment improve outcomes, but this is hampered by disagreement regarding many aspects of its diagnosis. The diagnosis is based on maternity glucose concentrations measured by oral glucose tolerance test (OGTT) at 24–28 weeks of gestation. However, there are still many women who are at serious risk for over- and under-diagnosis due to the uncertainty of the ‘healthy’ glucose threshold. Furthermore, poorly controlled GDM leads to adverse maternal and infant outcomes. Therefore, the development of a reliable quantitate measure for early and accurate diagnosis together with person-specific control of the condition is of utter importance and comprises the goal of this research. To achieve this goal, 25 women in each group of low- and high-risk of GDM development will be recruited, comprising 50 participants in total. We will look at the timing and variations of blood glucose via continuous glucose monitoring and will employ advanced methods of dynamic modelling to analyse data collected throughout pregnancy and soon after giving birth. Specifically, we will investigate and quantify intra- and inter- person variability in glucose variations throughout gestation, assess how glucose variations change from the non-diabetic stage to well-developed GDM and back to normal non-diabetic condition and how they are different in the low- and high- risk GDM groups. The 5-years study will be conducted at the University Hospitals Coventry and Warwickshire in collaboration with the School of Engineering of the University of Warwick.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
1) Type I or type II diabetes mellitus 2) Any physical disease or condition or treatment which, in the opinion of the investigator, makes the subject a poor candidate for the objectives of this study.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Warwick and funded by Engineering and Physical Sciences Research Council (EPSRC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 47498
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
